These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 19912581)
1. Novel antibody screening cells, MUT+Mur kodecytes, created by attaching peptides onto red blood cells. Heathcote D; Carroll T; Wang JJ; Flower R; Rodionov I; Tuzikov A; Bovin N; Henry S Transfusion; 2010 Mar; 50(3):635-41. PubMed ID: 19912581 [TBL] [Abstract][Full Text] [Related]
2. Prevalence and specificity of red-blood-cell antibodies in a multiethnic South and East Asian patient population and influence of using novel MUT+Mur+ kodecytes on its detection. Nadarajan VS; Laing AA; Saad SM; Usin M Vox Sang; 2012 Jan; 102(1):65-71. PubMed ID: 21592136 [TBL] [Abstract][Full Text] [Related]
3. Synthetic glycolipid modification of red blood cell membranes. Frame T; Carroll T; Korchagina E; Bovin N; Henry S Transfusion; 2007 May; 47(5):876-82. PubMed ID: 17465953 [TBL] [Abstract][Full Text] [Related]
4. Mapping the fine specificity of ABO monoclonal reagents with A and B type-specific function-spacer-lipid constructs in kodecytes and inkjet printed on paper. Barr K; Korchagina E; Ryzhov I; Bovin N; Henry S Transfusion; 2014 Oct; 54(10):2477-84. PubMed ID: 24749871 [TBL] [Abstract][Full Text] [Related]
5. Flow cytometry evaluation of red blood cells mimicking naturally occurring ABO subgroups after modification with variable amounts of function-spacer-lipid A and B constructs. Hult AK; Frame T; Chesla S; Henry S; Olsson ML Transfusion; 2012 Feb; 52(2):247-51. PubMed ID: 21812783 [TBL] [Abstract][Full Text] [Related]
6. Modeling transfusion reactions and predicting in vivo cell survival with kodecytes. Oliver C; Blake D; Henry S Transfusion; 2011 Aug; 51(8):1723-30. PubMed ID: 21303367 [TBL] [Abstract][Full Text] [Related]
7. Synthetic peptides homologous to human glycophorins of the Miltenberger complex of variants of MNSs blood group system specify the epitopes for Hil, SJL, Hop, and Mur antisera. Johe KK; Vengelen-Tyler V; Leger R; Blumenfeld OO Blood; 1991 Nov; 78(9):2456-61. PubMed ID: 1718498 [TBL] [Abstract][Full Text] [Related]
8. Selection of GP. Mur antigen-negative RBC for blood recipients with anti-'Mi Yang CA; Lin JA; Chang CW; Wu KH; Yeh SP; Ho CM; Chang JG Transfus Med; 2016 Oct; 26(5):349-354. PubMed ID: 27634577 [TBL] [Abstract][Full Text] [Related]
9. The prevalence, immunogenicity, and evanescence of alloantibodies to MUT and Mur antigens of GP.Mur red blood cells in a Southeast Asian patient cohort. Nadarajan VS Transfusion; 2018 May; 58(5):1189-1198. PubMed ID: 29441590 [TBL] [Abstract][Full Text] [Related]
10. Universal Detection of Mi Yang MH; Chen JW; Sayaka K; Uchikawa M; Tsuno NH; Wei ST; Hou SM; Chen YJ Diagnostics (Basel); 2021 Apr; 11(5):. PubMed ID: 33946749 [TBL] [Abstract][Full Text] [Related]
11. Novel single-nucleotide change in GYP*A in a person who made an alloantibody to a new high-prevalence MNS antigen called ENEV. Velliquette RW; Hu Z; Lomas-Francis C; Hue-Roye K; Allen JL; Mirabella D; Reid ME Transfusion; 2010 Apr; 50(4):856-60. PubMed ID: 20003059 [TBL] [Abstract][Full Text] [Related]
12. Simulated RBC antibody identification training panels created using SARS-CoV-2 kodecytes and immune plasma. Perry H; Henry SM Transfusion; 2022 Aug; 62(8):1630-1635. PubMed ID: 35761783 [TBL] [Abstract][Full Text] [Related]
13. An alloantibody to a high-prevalence MNS antigen in a person with a GP.JL/Mk phenotype. Ratliff J; Veneman S; Ward J; Lomas-Francis C; Hue-Roye K; Velliquette RW; Sausais L; Maldonado T; Miyamoto J; Martin Y; Slater D; Reid ME Immunohematology; 2007; 23(4):146-9. PubMed ID: 18284304 [TBL] [Abstract][Full Text] [Related]
14. Frequencies of glycophorin variants and alloantibodies against Hil and MINY antigens in Japanese. Kaito S; Suzuki Y; Masuno A; Isa K; Toyoda C; Onodera T; Ogasawara K; Uchikawa M; Tsuno NH; Satake M Vox Sang; 2022 Jan; 117(1):94-98. PubMed ID: 34227688 [TBL] [Abstract][Full Text] [Related]
15. Surface decoration of red blood cells with maleimidophenyl-polyethylene glycol facilitated by thiolation with iminothiolane: an approach to mask A, B, and D antigens to generate universal red blood cells. Nacharaju P; Boctor FN; Manjula BN; Acharya SA Transfusion; 2005 Mar; 45(3):374-83. PubMed ID: 15752155 [TBL] [Abstract][Full Text] [Related]
16. Genetically engineered pig red blood cells for clinical transfusion: initial in vitro studies. Long C; Hara H; Pawlikowski Z; Koike N; d'Arville T; Yeh P; Ezzelarab M; Ayares D; Yazer M; Cooper DK Transfusion; 2009 Nov; 49(11):2418-29. PubMed ID: 19624491 [TBL] [Abstract][Full Text] [Related]
17. A direct blood polymerase chain reaction approach for the determination of GP.Mur (Mi.III) and other Hil+ Miltenberger glycophorin variants. Hsu K; Lin YC; Chang YC; Chan YS; Chao HP; Lee TY; Lin M Transfusion; 2013 May; 53(5):962-71. PubMed ID: 22924868 [TBL] [Abstract][Full Text] [Related]
18. Four examples of anti-TSEN and three of TSEN-positive erythrocytes. Storry JR; Lindsay G; Rolih S; Co A; Rodberg K; Harris T; Reid ME Vox Sang; 2000; 79(3):175-9. PubMed ID: 11111237 [TBL] [Abstract][Full Text] [Related]
19. The distribution of MNS hybrid glycophorins with Mur antigen expression in Chinese donors including identification of a novel GYP.Bun allele. Wei L; Shan ZG; Flower RL; Wang Z; Wen JZ; Luo GP; Ji YL Vox Sang; 2016 Oct; 111(3):308-314. PubMed ID: 27232276 [TBL] [Abstract][Full Text] [Related]
20. Novel GYP(A-B-A) hybrid gene in a DANE+ person who made an antibody to a high-prevalence MNS antigen. Velliquette RW; Palacajornsuk P; Hue-Roye K; Lindgren S; Ilstrup S; Green C; Lomas-Francis C; Reid ME Transfusion; 2008 Dec; 48(12):2618-23. PubMed ID: 18764826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]